PAR 2.04% 24.0¢ paradigm biopharmaceuticals limited..

Ann: Change of Director's Interest Notice, page-15

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 696 Posts.
    lightbulb Created with Sketch. 46
    I generally agree. You have to incentivise good talent. However, it doesn't show that the company's leadership is looking out for the rest of the shareholders of they use their weight to simply overthrow the popular vote.
    As I've said previously, I do feel that the company will come good long term, but a lot of investors have lost serious time in market due to a lack of transparency on part of the board and it's something of a kick in the teeth when they get issued performance shares for not performing to their own standards and deadlines.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
-0.005(2.04%)
Mkt cap ! $83.98M
Open High Low Value Volume
25.0¢ 25.5¢ 24.0¢ $202.2K 814.1K

Buyers (Bids)

No. Vol. Price($)
5 181098 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 118621 5
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.